To investigate whether miR-101 enhances anti-tumor effect of TRAIL on PTC in vivo, we established a TPC-1 xenograft model by subcutaneously inoculating with TPC-1 cells which were transfected with lentivirus carrying miR-101 precursor sequence on nude mice. Here, TNFSF10 is linked to neoplasm.